Subscribe

Stay Informed. Stay Ahead.

Subscribe to receive curated updates, expert insights, and practical education—delivered straight to your inbox.

Get timely coverage on new approvals, case-based discussions, conference highlights, and practical tools for everyday practice in community oncology and hematology.

Subscribe
*
Skip to main content
OncUpdates
  • Conferences
    • ASCO GU
    • ASCO GI
    • ASH
    • SABCS
    • ESMO
    • WCLC
    • ASCO
  • Videos & Podcasts
    • Challenging Cases
      • Hematology
      • Lung Cancer
      • Breast Cancer
      • GU Oncology
    • New Approvals
      • Hematology
      • GI Oncology
      • GU Oncology
      • Lung Cancer
      • Breast Cancer
    • Tox Check
      • GI Oncology
      • GU Oncology
      • Lung Cancer
      • Breast Cancer
      • Hematology
    • Treatment Algorithms
      • Dermatology
      • Hematology
      • Lung Cancer
      • Ovarian Cancer
  • Clinical Insights
    • GU Oncology
      • Bladder Cancer
      • MIBC
      • RCC
    • GI Oncology
      • Gastroesophageal Cancer
      • Gastric/GEJ Cancer
    • Breast Cancer
      • Early HR+
      • Metastatic HR+
    • Hematology
      • Polycythemia Vera
    • Lung Cancer
      • SCLC
      • NSCLC
  • Resource Centers
    • Pancreatic Cancer
    • Metastatic Breast Cancer
  • Articles
    • GI Oncology
    • Hematology
    • Lung Cancer
  • Events
  • Conferences
    • ASCO GU
    • ASCO GI
    • ASH
    • SABCS
    • ESMO
    • WCLC
    • ASCO
  • Videos & Podcasts
    • Challenging Cases
      • Hematology
      • Lung Cancer
      • Breast Cancer
      • GU Oncology
    • New Approvals
      • Hematology
      • GI Oncology
      • GU Oncology
      • Lung Cancer
      • Breast Cancer
    • Tox Check
      • GI Oncology
      • GU Oncology
      • Lung Cancer
      • Breast Cancer
      • Hematology
    • Treatment Algorithms
      • Dermatology
      • Hematology
      • Lung Cancer
      • Ovarian Cancer
  • Clinical Insights
    • GU Oncology
      • Bladder Cancer
      • MIBC
      • RCC
    • GI Oncology
      • Gastroesophageal Cancer
      • Gastric/GEJ Cancer
    • Breast Cancer
      • Early HR+
      • Metastatic HR+
    • Hematology
      • Polycythemia Vera
    • Lung Cancer
      • SCLC
      • NSCLC
  • Resource Centers
    • Pancreatic Cancer
    • Metastatic Breast Cancer
  • Articles
    • GI Oncology
    • Hematology
    • Lung Cancer
  • Events

Explore Videos, Articles & More

Tox Check

Managing the manageable—real-world insights on side effect strategies to keep treatments on track.
Practical strategies for managing toxicity, educating patients, and modifying doses—ensuring treatments remain effective and tolerable in community settings.

Home / Videos & Podcasts / Tox Check

HEMATOLOGY

Browse all HEMATOLOGY
How to Manage Side Effects of Tyrosine Kinase Inhibitors in CML

HEMATOLOGY

How to Manage Side Effects of Tyrosine Kinase Inhibitors in CML

Fadi Haddad, MD, Onyee Chan, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

BREAST CANCER

Browse all BREAST CANCER
PI3K/AKT Inhibitor Side Effect Management in Metastatic Breast Cancer

BREAST CANCER

PI3K/AKT Inhibitor Side Effect Management in Metastatic Breast Cancer

Emily Gallagher, MD, PhD, Neil Iyengar, MD, Rohit Gosain, MD, Rahul Gosain, MD, MBA

Managing Side Effects of CDK4/6 Inhibitors in Breast Cancer

BREAST CANCER

Managing Side Effects of CDK4/6 Inhibitors in Breast Cancer

Stephanie Graff, MD, FACP, FASCO, Rahul Gosain, MD, MBA, Rohit Gosain, MD

GI ONCOLOGY

Browse all GI ONCOLOGY
Managing Side Effects of Panitumumab, Cetuximab, and Bevacizumab

GI ONCOLOGY

Managing Side Effects of Panitumumab, Cetuximab, and Bevacizumab

Pashtoon Kasi, MD, MS

Managing Toxicities of FOLFIRINOX and Nab-Paclitaxel Plus Gemcitabine

GI ONCOLOGY

Managing Toxicities of FOLFIRINOX and Nab-Paclitaxel Plus Gemcitabine

Midhun Malla, MD, Rachna Shroff, MD, MS, FASCO

LUNG CANCER

Browse all LUNG CANCER
Key Adverse Effects of Novel Antibody-Drug Conjugates in NSCLC

LUNG CANCER

Key Adverse Effects of Novel Antibody-Drug Conjugates in NSCLC

Jacob Sands, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

Optimizing ROS1 Inhibitor Therapy in NSCLC

LUNG CANCER

Optimizing ROS1 Inhibitor Therapy in NSCLC

Estelamari Rodriguez, MD, MPH, Rohit Gosain, MD, Rahul Gosain, MD, MBA

How to Manage Anti-EGFR Toxicities in NSCLC

LUNG CANCER

How to Manage Anti-EGFR Toxicities in NSCLC

Gilberto Lopes, MD

GU ONCOLOGY

Browse all GU ONCOLOGY
Strategies to Minimize Side Effects in RCC Treatment

GU ONCOLOGY

Strategies to Minimize Side Effects in RCC Treatment

Sumanta Pal, MD, FASCO, Rahul Gosain, MD, MBA, Rohit Gosain, MD

OncUpdates

Empowering oncology professionals with The latest insights, breakthroughs, And expert opinions

Quick Links

  • About Us
  • Upcoming Events
  • Contact Us
  • Follow on X
  • Follow on LinkedIn

Legal

  • Terms of Use
  • Privacy Policy
  • Cookie Settings
  • Authors

Subscribe to Our Newsletters


Property of SignifyMD LLC, All Rights Reserved 2026 SignifyMD LLC PO Box 512, Brielle, NJ 08730


Oncology Resources | Hematology Support | Community Oncology